Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Syncom Formulations Ltd.

BSE: 524470 | NSE: SYNCOMF |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE312C01025 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Mar 24, 09:26
11.49 0.25 (2.22%)
Volume
AVERAGE VOLUME
5-Day
231,882
10-Day
196,003
30-Day
189,806
74,411
  • Prev. Close

    11.24

  • Open Price

    11.75

  • Bid Price (Qty.)

    11.51 (2444)

  • Offer Price (Qty.)

    11.55 (2952)

NSE Live

Mar 24, 09:26
11.57 0.38 (3.40%)
Volume
AVERAGE VOLUME
5-Day
1,947,073
10-Day
1,716,997
30-Day
1,612,057
318,064
  • Prev. Close

    11.19

  • Open Price

    11.85

  • Bid Price (Qty.)

    11.54 (9500)

  • Offer Price (Qty.)

    11.59 (664)

Financials

Profit & Loss account of Syncom Formulations (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 167.77 147.41 111.74 112.56 73.02  
Less: Excise/Sevice Tax/Other Levies 0.11 0.36 0.02 0.03 0.03  
Revenue From Operations [Net] 167.66 147.05 111.72 112.53 72.99  
Total Operating Revenues 173.39 151.29 114.95 118.45 76.32  
Other Income 1.98 1.12 1.15 0.94 0.36  
Total Revenue 175.37 152.41 116.10 119.39 76.69  
EXPENSES  
Cost Of Materials Consumed 89.84 70.96 52.52 63.48 37.97  
Purchase Of Stock-In Trade 26.90 32.11 25.52 16.43 9.74  
Operating And Direct Expenses 4.13 3.29 2.43 2.64 1.74  
Changes In Inventories Of FG,WIP And Stock-In Trade -0.75 -1.35 -0.50 3.19 -1.05  
Employee Benefit Expenses 13.50 11.43 10.15 10.47 10.38  
Finance Costs 0.21 0.36 0.43 0.42 0.40  
Depreciation And Amortisation Expenses 3.43 3.07 2.91 2.72 2.45  
Other Expenses 21.60 18.61 14.20 14.59 14.61  
Total Expenses 158.88 138.48 107.65 113.93 76.24  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 16.49 13.93 8.45 5.46 0.45  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 16.49 13.93 8.45 5.46 0.45  
Tax Expenses-Continued Operations  
Current Tax 5.37 4.32 2.28 1.09 0.08  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 0.23 -0.29 0.46 0.86 0.04  
Tax For Earlier Years 0.27 0.59 0.05 0.01 0.12  
Total Tax Expenses 5.88 4.61 2.79 1.96 0.24  
Profit/Loss After Tax And Before ExtraOrdinary Items 10.61 9.32 5.66 3.51 0.20  
Profit/Loss From Continuing Operations 9.76 9.32 5.66 3.51 0.20  
Profit/Loss For The Period 9.76 9.32 5.66 3.51 0.20  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 0.12 0.12 2.54 1.57 0.14  
Diluted EPS (Rs.) 0.12 0.12 2.54 1.57 0.14  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 89.84 70.96 52.52 63.48 37.97  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 1.56 1.56 1.34 1.34 1.12  
Tax On Dividend 0.32 0.27 0.22 0.22 0.18  
Equity Dividend Rate (%) 2.00 2.00 6.00 6.00 5.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347